MAPT and Alzheimer disease: Equally, in light of the facilitation of fibril seeding by the existence of pre-existing tau phosphorylation/pathology in mice [16, 25, 32], the targeting of pre-tangle soluble tau elevations in late-stage-affected brain regions, may protect against tau seed infiltration as part of AD disease progression and may provide an effective stalling of the condition.